Form4insider filings, from the source

SEC Form 4 · accession 0000911916-16-000579

CoLucid Pharmaceuticals, Inc. · CLCD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas P. Mathers
Officer — Chief Executive Officer · Director
Period of report
Jun 5, 2016
Accepted (ET)
Jun 7, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 5, 2016M3,756—A250,156D
Common StockF3,F4Jun 6, 2016S1,502$7.2463D248,654D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F5—Jun 5, 2016M3,756D——Common Stock3,756131,434D

Explanation of responses